Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-07-30

FDA Approved: XEOMIN — Original Application (Merz Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved Xeomin (incobotulinumtoxinA) from Merz Pharmaceuticals in an original Biologics License Application. It established initial indications for cervica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XEOMIN (INCOBOTULINUMTOXINA)

Snippet

ORIG AP for XEOMIN (INCOBOTULINUMTOXINA)